Patents by Inventor Emanuel Escher

Emanuel Escher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Quantum dot template for fast and simultaneous detection of different infectious agents
    Patent number: 8709708
    Abstract: A method and a device for detecting the presence of a predetermined substance, in which a quantum dot is produced on a substrate. The quantum dot emits a radiation at a predetermined wavelength, and is covered with a surface layer to which the predetermined substance attaches. A deviation of the value of a parameter related to the radiation is produced when the predetermined substance attaches to the surface layer. This deviation can be detected to thereby sense the presence of the predetermined substance.
    Type: Grant
    Filed: March 10, 2006
    Date of Patent: April 29, 2014
    Assignee: Societe de Commercialisation des Produits de la Recherche Appliquee SOCPRA-Sciences et Genie S.E.C.
    Inventors: Jan J. Dubowski, Ximing Ding, Eric H. Frost, Emanuel Escher
  • Caloxins
    Patent number: 7091174
    Abstract: Novel compound called caloxins which are extracellular plasma membrane (PM) Ca2+-pump inhibitors are described. One caloxin is caloxin 2A1 and has the amino acid sequence VSNSNWPSFPSSGGG. Another caloxin is caloxin 3A1 and has the amino acid sequence DSHINNEPSRRRGGGK. The caloxins are useful in inhibiting PM Ca2+-pumps and can be used in the development of treatments of various diseases including hypertension, hypotension, degenerative brain disorders, mood disorders, diabetes, kidney failure and cancer.
    Type: Grant
    Filed: October 5, 2001
    Date of Patent: August 15, 2006
    Assignee: McMaster University
    Inventors: Ashok K. Grover, Emanuel Escher, Jyoti Chaudhary
  • Caloxins
    Publication number: 20040096898
    Abstract: Novel compound called caloxins which are extracellular plasma membrane (PM) Ca2+-pump inhibitors are described. One caloxin is caloxin 2A1 and has the amino acid sequence VSNSNWPSFPSSGGG. Another caloxin is caloxin 3A1 and has the amino acid sequence DSHINNEPSRRRGGGK. The caloxins are useful in inhibiting PM Ca2+-pumps and can be used in the development of treatments of various diseases including hypertension, hypotension, degenerative brain disorders, mood disorders, diabetes, kidney failure and cancer.
    Type: Application
    Filed: October 10, 2003
    Publication date: May 20, 2004
    Inventors: Ashok K. Grover, Emanuel Escher, Jyoti Chaudhary